Structural motifs of pituitary adenylate cyclase-activating polypeptide (PACAP) defining PAC1-receptor selectivity (Q40963606)

25 September 2017

title

Structural motifs of pituitary adenylate cyclase-activating polypeptide (PACAP) defining PAC1-receptor selectivity (English)

1 reference

25 September 2017

Schäfer H

1

1 reference

25 September 2017

Zheng J

2

1 reference

25 September 2017

Morys-Wortmann C

3

1 reference

25 September 2017

Fölsch UR

4

1 reference

25 September 2017

Schmidt WE

5

1 reference

25 September 2017

publication date

1 February 1999

1 reference

25 September 2017

1 reference

25 September 2017

volume

79

1 reference

25 September 2017

issue

2-3

1 reference

25 September 2017

page(s)

83-92

1 reference

Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38).

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

Molecular cloning and characterization of cDNA for the precursor of rat pituitary adenylate cyclase activating polypeptide (PACAP).

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

A novel peptide which stimulates adenylate cyclase: molecular cloning and characterization of the ovine and human cDNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

Pituitary adenylate cyclase activating peptide: a novel vasoactive intestinal peptide-like neuropeptide in the gut.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

Pituitary adenylate cyclase activating peptide and vasoactive intestinal polypeptide: differentiation effects on human neuroblastoma NB-OK-1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

Effects of a novel hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide, on pituitary hormone release in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

Effect of pituitary adenylate cyclase activating polypeptide on rat pancreatic exocrine secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

PACAP-38, a novel peptide from ovine hypothalamus, is a potent modulator of amylase release from dispersed acini from rat pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

PACAP and VIP stimulate enzyme secretion in rat pancreatic acini via interaction with VIP/PACAP-2 receptors: additive augmentation of CCK/carbachol-induced enzyme release

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

Pituitary adenylate cyclase activating polypeptide provokes cultured rat chromaffin cells to secrete adrenaline

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

Pituitary adenylate cyclase activating peptide, a novel VIP-like gut-brain peptide, relaxes the guinea-pig taenia caeci via apamin-sensitive potassium channels

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

Pituitary adenylate cyclase activating polypeptide (PACAP) is a potent relaxant of the rat ileum

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

Stimulation of rat pancreatic tumoral AR4-2J cell proliferation by pituitary adenylate cyclase-activating peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

PACAP stimulates transcription of c-Fos and c-Jun and activates the AP-1 transcription factor in rat pancreatic carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

Differential signal transduction by five splice variants of the PACAP receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

The VIP2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

Cloning of a splice variant of the pituitary adenylate cyclase-activating polypeptide (PACAP) type I receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

Two high affinity binding sites for pituitary adenylate cyclase-activating polypeptide have different tissue distributions

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

Hypothalamic binding sites for pituitary adenylate cyclase activating polypeptide: characterization and molecular identification 1

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

Characterization of a guanosine-nucleotide-binding-protein-coupled receptor for pituitary adenylate-cyclase-activating polypeptide on plasma membranes from rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

The novel VIP-like hypothalamic polypeptide PACAP interacts with high affinity receptors in the human neuroblastoma cell line NB-OK.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

Characterization and purification of the solubilized pituitary adenylate-cyclase-activating polypeptide-1 receptor from porcine brain using a biotinylated ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

Expression of pituitary adenylate cyclase activating peptide (PACAP) and PACAP type I receptors in the rat adrenal medulla

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4-2J.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

Contrasting effects of PACAP and carbachol on [Ca2+]i and inositol phosphates in human neuroblastoma NB-OK-1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

Pituitary adenylate-cyclase-activating polypeptide stimulates proto-oncogene expression and activates the AP-1 (c-Fos/c-Jun) transcription factor in AR4-2J pancreatic carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

Binding sites of a novel neuropeptide pituitary-adenylate-cyclase-activating polypeptide in the rat brain and lung

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

Vasoactive intestinal peptide receptors in pancreas and liver. Structure-function relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP(6-38) as a potent antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

A chimeric VIP-PACAP analogue but not VIP pseudopeptides function as VIP receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

Structural requirements for the binding of the pituitary adenylate-cyclase-activating peptide to receptors and adenylate-cyclase activation in pancreatic and neuronal membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

C-terminally shortened pituitary adenylate cyclase-activating peptides (PACAP) discriminate PACAP I, PACAP II-VIP1 and PACAP II-VIP2 recombinant receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

Addition of the (28-38) peptide sequence of PACAP to the VIP sequence modifies peptide selectivity and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900147-5

7 January 2021

10.1016/S0167-0115(98)00147-5

Identifiers

DOI

1 reference

25 September 2017

1 reference